Alzinova AB (SE0007413455) — research page
SE · se-cm-kg/SSME/SE0007413455 · as of 2026-11-06
Identity and listing
The issuer is Alzinova AB, listed on First North Sweden under ticker SE0007413455, with ISIN SE0007413455 and LEI 549300K3IMVT20EK2S13. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Alzinova AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0007413455 | source · 2026-11-06 |
| ISIN | SE0007413455 | source · 2026-11-06 |
| LEI | 549300K3IMVT20EK2S13 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 47 filings on 43 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6.0 days. The latest filing is dated 2026-11-03, 3 days before the record date of 2026-11-06, and is of type Investor News. The exchange median for First North Sweden is 11.0 days of cadence, 21 filings and 7 days of latency across 325 issuers. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 47 | 6 | 3 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-03 | Investor News | Investor News | Alzinova moves closer to Phase 2a initiation with US ethics submission |
| 2026-11-02 | Investor News | Investor News | Alzinova takes further step toward Phase 2a ADVANCE study with submitted FDA amendment for ALZ-101 |
| 2026-10-21 | Investor News | Investor News | Alzinova finalises selection of seven US clinical sites as ADVANCE Phase 2a study moves toward first participant enrolment |
| 2026-10-20 | Company Announcement | Company Announcement | Alzinova's Board of Directors resolves on a directed issue of units to underwriters in connection with the completed rights issue |
| 2026-10-08 | Investor News | Investor News | Alzinova to present latest developments in ALZ-101 and blood-based diagnostics at Redeye Neurology Day |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
The outcome is not determinable under rule version acm-68000/se/mifid-ii-product-governance/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations page.
Open research
The record holds 4 openly published research notes: BioStock Analytics on 2026-07-07, Carnegie Securities Research on 2025-01-27, Redeye on 2023-02-23, and Redeye on 2021-11-01.
| date | publisher | note | kind |
|---|---|---|---|
| 2026-07-07 | BioStock Analytics | Alzinova AB · Commissioned Valuation Analysis | issuer-sponsored |
| 2025-01-27 | Carnegie Securities Research | Alzinova | issuer-sponsored |
| 2023-02-23 | Redeye | Update | independent |
| 2021-11-01 | Redeye | Ready to ignite – Initiating clinical development | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0007413455 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.alzinova.com/wp-content/uploads/2026/07/alzinova-ab-commissioned-valuation-analysis-biostock-analytics-july2026.pdf (open research)
- 10.7
- https://www.alzinova.com/wp-content/uploads/2025/02/alzi_250127.pdf (open research)
- 10.8
- https://www.alzinova.com/wp-content/uploads/2023/02/redeye-updated-report-2023-02-23.pdf (open research)
- 10.9
- https://www.alzinova.com/wp-content/uploads/2021/11/redeye_report_2021-11-01.pdf (open research)
- 10.10
- https://mcp.se-cm-kg.ai/record/SSME/SE0007413455 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0007413455"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a1b73dd42f8c8b9f.